Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04102345 · ClinicalTrials.gov registry record · Early Phase 1
Lavender vs Zolpidem Sleep Quality During Diagnostic PSG
A Early Phase 1 study, sponsored by HealthPartners Institute.
- Completed
- Registry status
- Early Phase 1
- Development phase
- 58
- Enrollment target
NCT04102345 is a Early Phase 1 study that has completed, run by HealthPartners Institute. The registered enrollment target is 58 participants.
The verdict
NCT04102345, a Early Phase 1 study, has completed, sponsored by HealthPartners Institute.
- COMPLETED
- Registry status
- Early Phase 1
- Development phase
- 58 participants
- Enrollment target
Study Summary
In this pragmatic, clinical study the investigators propose that lavender aromatherapy is comparable to Zolpidem (Ambien) in improving the quality of diagnostic sleep studies.
Interventions
- OTHER Lavender Aromatherapy
- DRUG Zolpidem
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 58 participants |
| Start Date | 2019-09-04 |
| Est. Completion | 2020-11-10 |
| Phase | Early Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04102345
The ClinicalTrials.gov registry entry for NCT04102345 describes a study currently listed as completed, categorized as Early Phase 1. The registered enrollment target is 58 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is HealthPartners Institute, which has 146 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Lavender Aromatherapy is the first listed.
NCT04102345 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04102345 about?
NCT04102345 is a clinical study titled "Lavender vs Zolpidem Sleep Quality During Diagnostic PSG". In this pragmatic, clinical study the investigators propose that lavender aromatherapy is comparable to Zolpidem (Ambien) in improving the quality of diagnostic sleep studies.
What is the current status of trial NCT04102345?
This trial is currently completed. It is a Early Phase 1 study. The enrollment target is 58 participants. The study started on 2019-09-04. Estimated completion is 2020-11-10.
What interventions are being tested in trial NCT04102345?
The interventions under investigation include: Lavender Aromatherapy (OTHER), Zolpidem (DRUG).
Who is sponsoring clinical trial NCT04102345?
This trial is sponsored by HealthPartners Institute, which has 146 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.